Monday, 20 May 2019

You are here

Dr. Olga Petryna - Canakinumab in CVD Pts Prevents Acute Gout Attacks

Dr. Petryna reviews Dr. Dan Solomon's EULAR 2018 plenary presentation showing a 50-60% reduction in acute gout amongst CVD patients treated with canakinumab.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

Dr. Cush and Dr. Pope: Rheumatoid...

29 Oct 2018

Dr. Arthur Kavanaugh: Biosimilars and...

30 Jan 2017

The Week in Review - 11 March 2016

11 Mar 2016

RheumNow Live Preview with Dr. Georg...

12 Apr 2019

Dr. Arthur Kavanaugh: Predictors

21 Oct 2018

Dr. Brittany Ahmed: Rheumatology...

23 Oct 2018

Dr. Sam Whittle: Five Factors in Gout

22 Oct 2018

RheumNow Podcast - Death and Surgery (2...

22 Feb 2019

Arthur F. Kavanaugh, MD: sessions on...

12 Nov 2015

Dr. Gregg Silverman: The Microbiome and...

05 Nov 2017

Drs. Mease, Cush and Ruderman:...

24 Oct 2018

QD Video - Non-Traumatic Hemarthrosis

18 Jan 2019